IPC분류정보
국가/구분 |
United States(US) Patent
등록
|
국제특허분류(IPC7판) |
|
출원번호 |
US-0438529
(2003-05-15)
|
발명자
/ 주소 |
- Livisay,Stacy A.
- Lavoie,James P.
|
출원인 / 주소 |
|
대리인 / 주소 |
|
인용정보 |
피인용 횟수 :
0 인용 특허 :
31 |
초록
▼
Methods of making a calcium fortified, tartaric acid-containing product that is essentially free of tartrate precipitates. The tartaric acid concentration of a precursor is adjusted to form an adjusted precursor. An additive comprising a calcium-based compound is mixed with the adjusted precursor to
Methods of making a calcium fortified, tartaric acid-containing product that is essentially free of tartrate precipitates. The tartaric acid concentration of a precursor is adjusted to form an adjusted precursor. An additive comprising a calcium-based compound is mixed with the adjusted precursor to make the fortified product. The compound may be calcium gluconate, a variety of other compounds or mixtures thereof. The fortified product, when stored at approximately 70째 F., may remain essentially free of tartrate precipitate for at least sixteen weeks. The fortified, tartaric acid-containing products processed by the disclosed methods.
대표청구항
▼
We claim: 1. A method of making a calcium-fortified, tartaric acid-containing single strength 100% grape juice, the method comprising: providing a tartaric acid-containing precursor; lowering tartaric acid concentration of the precursor to form an adjusted precursor having an adjusted tartaric acid
We claim: 1. A method of making a calcium-fortified, tartaric acid-containing single strength 100% grape juice, the method comprising: providing a tartaric acid-containing precursor; lowering tartaric acid concentration of the precursor to form an adjusted precursor having an adjusted tartaric acid concentration no greater than 0.30 g/100 mL; and mixing the adjusted precursor with an additive, the additive comprising: a calcium-based compound, to provide a single strength grape juice product fortified with a predetermined amount of bioavailable calcium and essentially free of tartrate precipitates. 2. A method according to claim 1, wherein the single strength grape juice product is a single strength white grape juice product. 3. A method according to claim 1, wherein, in providing, the tartaric acid-containing precursor contains a tartaric acid concentration greater than approximately 0.40 g/100 mL. 4. A method according to claim 1, wherein, in providing, the tartaric acid-containing precursor contains a tartaric acid concentration greater than 0.10 g/100 mL, and in lowering, the adjusted tartaric acid concentration is no greater than 0.10 g/100 mL. 5. A method according to claim 1, wherein, in providing, the tartaric acid-containing precursor contains a tartaric acid concentration greater than 0.17 g/100 mL, and in lowering, the adjusted tartaric acid concentration is no greater than 0.17 g/100 mL. 6. A method according to claim 1, wherein, in providing, the tartaric acid containing precursor is a grape juice concentrate. 7. A method according to claim 1, wherein, in providing, the tartaric acid containing precursor is a single strength grape juice. 8. A method according to claim 1, wherein, in lowering, lowering includes mixing the tartaric acid-containing precursor with water. 9. A method according to claim 1, wherein, in mixing, the calcium-based compound is selected from calcium gluconate, calcium carbonate, calcium oxide, calcium orthophosphate, calcium glubionate, calcium lactate, calcium gluceptate, calcium levulinate, calcium lactophosphate, calcium citrate, calcium chloride, calcium malate, calcium phosphate, calcium disodium EDTA, and combinations thereof. 10. A method according to claim 1, wherein the predetermined amount of bioavailable calcium in a serving of the single strength grape juice product ranges from approximately 8% to approximately 35% of required daily intake for a human. 11. A method according to claim 1, wherein the predetermined amount of bioavailable calcium in a serving of the single strength grape juice product is at least approximately 10% of required daily intake for a human. 12. A method according to claim 1, wherein, in lowering, the adjusted tartaric acid concentration is no greater than approximately 0. 21 g/100 mL, and the predetermined amount of bioavailable calcium in a serving of the single strength grape juice product is at least approximately 20% of required daily intake for a human. 13. A method according to claim 1, wherein, in lowering, the adjusted tartaric acid concentration is no greater than approximately 0. 21 g/100 mL, and the predetermined amount of bioavailable calcium in a serving of the single strength grape juice product ranges from approximately 8% to approximately 35% of required daily intake for a human. 14. A method according to claim 1, wherein, in lowering, the adjusted tartaric acid concentration is no greater than approximately 0. 17 g/100 mL, and the predetermined amount of bioavailable calcium in a serving of the single strength grape juice product is approximately 35% of required daily intake for a human. 15. A method according to claim 1, wherein, in lowering, the adjusted tartaric acid concentration is at least approximately 0.005 g/100 mL. 16. A method according to claim 15, wherein, in lowering, the adjusted tartaric acid concentration is at least approximately 0.07 g/100 mL. 17. A method according to claim 16, wherein, in mixing, the calcium-based compound comprises calcium gluconate. 18. A method according to claim 1, wherein, in mixing, the calcium-based compound comprises calcium gluconate. 19. A fortified tartaric-acid containing single strength grape juice product processed according to any one of claims 1-18. 20. A method of making a calcium-fortified, tartaric acid-containing product, the method comprising: providing a tartaric acid-containing precursor; lowering tartaric acid concentration of the precursor to form an adjusted precursor; having an adjusted tartaric acid concentration no greater than 0.30 g/100 mL; and mixing the adjusted precursor with an additive, the additive comprising: a calcium-based compound that comprises calcium gluconate, to provide a product fortified with a predetermined amount of bioavailable calcium and essentially free of tartrate precipitates. 21. A method according to claim 20, wherein, in mixing, the calcium-based compound consists essentially of calcium gluconate. 22. A method according to claim 20, wherein, in lowering, the adjusted tartaric acid concentration is at least approximately 0.005 g/100 mL. 23. A method according to claim 20, wherein, in lowering, lowering includes mixing the tartaric acid-containing precursor with a fruit-based liquid. 24. A method according to claim 23, wherein, in lowering, lowering includes mixing the tartaric acid-containing precursor with a fruit juice concentrate. 25. A method according to claim 23, wherein, in lowering, lowering includes mixing the tartaric acid-containing precursor with a single strength fruit juice. 26. A method according to claim 23, wherein, in lowering, lowering includes mixing the tartaric acid-containing precursor with a fruit-based liquid that includes juice from at least one of apple, apricot, blackberry, boysenberry, cherry, cranberry, grape, grapefruit, lemon, lime, mango, orange, passion fruit, peach, pear, raspberry, strawberry, tangerine, and tomato. 27. A method according to claim 20, wherein, in lowering, lowering includes mixing the tartaric acid-containing precursor with water. 28. A method according to claim 20, wherein, in providing, the tartaric acid-containing precursor contains a tartaric acid concentration greater than approximately 0.40 g/100 mL. 29. A method according to claim 20, wherein, in providing, the tartaric acid-containing precursor contains a tartaric acid concentration greater than 0.10 g/100 mL, and in lowering, the adjusted tartaric acid concentration is no greater than 0.10 g/100 mL. 30. A method according to claim 20, wherein, in providing, the tartaric acid-containing precursor contains a tartaric acid concentration greater than 0.17 g/100 mL, and in lowering, the adjusted tartaric acid concentration is no greater than 0.17 g/100 mL. 31. A method according to claim 20, wherein, in providing, the tartaric acid containing precursor is a grape juice concentrate. 32. A method according to claim 20, wherein, in providing, the tartaric acid containing precursor is a single strength grape juice. 33. A method according to claim 20, wherein the predetermined amount of bioavailable calcium in 8 ounces of the product is at least approximately 10% of required daily intake for a human. 34. A method according to claim 33, wherein, in lowering, the adjusted tartaric acid concentration is no greater than approximately 0. 21 g/100 mL, and the predetermined amount of bioavailable calcium in 8 ounces of the product is at least approximately 20% of required daily intake for a human. 35. A method according to claim 34, wherein, in lowering, the adjusted tartaric acid concentration is no greater than approximately 0. 17 g/100 mL, and the predetermined amount of bioavailable calcium in 8 ounces of the product is at least approximately 35% of required daily intake for a human. 36. A fortified tartaric-acid containing product processed according to any one of claims 20-35. 37. A method of making a calcium-fortified, tartaric acid-containing product, the method comprising: providing a tartaric acid-containing precursor; lowering tartaric acid concentration of the precursor to form an adjusted precursor having an adjusted tartaric acid concentration no greater than 0.30 g/100 mL and at least approximately 0.07 g/100 mL; and mixing the adjusted precursor with an additive, the additive comprising: a calcium-based compound, to provide a product fortified with a predetermined amount of bioavailable calcium and essentially free of tartrate precipitates. 38. A method according to claim 37, wherein the predetermined amount of bioavailable calcium in a serving of the product is at least approximately 10% of required daily intake for a human. 39. A method according to claim 38, wherein, in lowering, the adjusted tartaric acid concentration is no greater than approximately 0. 21 g/100 mL, and the predetermined amount of bioavailable calcium in a serving of the product is at least approximately 20% of required daily intake for a human. 40. A method according to claim 39, wherein, in lowering, the adjusted tartaric acid concentration is no greater than approximately 0. 17 g/100 mL, and the predetermined amount of bioavailable calcium in a serving of the product is at least approximately 35% of required daily intake for a human. 41. A method according to claim 37, wherein, in mixing, the calcium-based compound comprises calcium gluconate. 42. A method according to claim 37, wherein, in lowering, lowering includes mixing the tartaric acid-containing precursor with a fruit-based liquid. 43. A method according to claim 42, wherein, in lowering, lowering includes mixing the tartaric acid-containing precursor with a fruit juice concentrate. 44. A method according to claim 42, wherein, in lowering, lowering includes mixing the tartaric acid-containing precursor with a single strength fruit juice. 45. A method according to claim 42, wherein, in lowering, lowering includes mixing the tartaric acid-containing precursor with a fruit-based liquid that includes juice from at least one of apple, apricot, blackberry, boysenberry, cherry, cranberry, grape, grapefruit, lemon, lime, mango, orange, passion fruit, peach, pear, raspberry, strawberry, tangerine, and tomato. 46. A method according to claim 37, wherein, in lowering, lowering includes mixing the tartaric acid-containing precursor with water. 47. A method according to claim 37, wherein, in mixing, the calcium-based compound is selected from calcium gluconate, calcium carbonate, calcium oxide, calcium orthophosphate, calcium glubionate, calcium lactate, calcium gluceptate, calcium levulinate, calcium lactophosphate, calcium citrate, calcium chloride, calcium malate, calcium phosphate, calcium disodium EDTA, and combinations thereof. 48. A method according to claim 37, wherein, in providing, the tartaric acid-containing precursor contains a tartaric acid concentration greater than approximately 0.40 g/100 mL. 49. A method according to claim 37, wherein, in providing, the tartaric acid-containing precursor contains a tartaric acid concentration greater than 0.10 g/100 mL, and in lowering, the adjusted tartaric acid concentration is no greater than 0.10 g/100 mL. 50. A method according to claim 37, wherein, in providing, the tartaric acid-containing precursor contains a tartaric acid concentration greater than 0.17 g/100 mL, and in lowering, the adjusted tartaric acid concentration is no greater than 0.17 g/100 mL. 51. A method according to claim 37, wherein, in providing, the tartaric acid containing precursor is a grape juice concentrate. 52. A method according to claim 37, wherein, in providing, the tartaric acid containing precursor is a single strength grape juice. 53. A fortified tartaric-acid containing product processed according to any one of claims 37-52.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.